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Purpose
To compare Acoustic Radiation Force Impulse imaging (ARFI of Siemens Acuson S2000) with Transient Elastography (TE of FibroScan) for investigating whether ARFI can be a feasible and accurate technique in the assessment of liver fibrosis. Viral hepatitis is a very common disease in the world with complications of cirrhosis, and liver cancer. In Viet Nam, the incidence of hepatitis B and C is more than 20% of the population (about 18 million people), of which one-fifth of the severe cases have complications if not properly treated. The degree of liver fibrosis is one of the most important criteria in planning treatment and monitoring of response.
Liver biopsy is still a gold standard for assessment of liver fibrosis staging. However, this is an expensive and invasive procedure with dangerous complications. Recently, Siemens Acuson S2000, Virtual Touch Tissue Quantification (VTQ) emerged as a new non-invasive elastographic quantification of liver fibrosis, which is fully integrated on a conventional ultrasound system. Many studies have shown ARFI in correlation with liver biopsy results and TE of Fibroscan. However, the sample size was small, and ARFI is not widely used in clinical practice yet. Therefore, it is necessary to have more research with a larger sample size to prove the accuracy, safety and benefits of ARFI technique in clinical practice.
We have conducted a study comparing the correlation between ARFI of Siemens Acuson S2000 Virtual Touch and TE of Fibroscan techniques in order to find out whether ARFI can be a feasible and accurate technique in the assessment of liver fibrosis.
Methods and Materials
This is a double-blind and descriptive cross-sectional study which was approved by the local Ethics Committee. All patients agree to participate in this study completely free of charge. We conducted the study on 586 cases at the Medic Medical Center from September 2011 to December 2012, including 369 males, 217 females, 382 cases of chronic viral hepatitis and 204 patients without HBV and HCV markers (94 healthy), ages from 17 to 85 years old (mean = 40.2 ± 13.4), BMI = 14.82 to 32.39 (mean = 22.22 ± 2.9).
All patients were examined by two sonologists performing ARFI and TE techniques; and serologic marker testing was done on the same day.
Two patients were excluded from the statistical analysis because FibroScan failed in measurement (one patient was overweight (BMI = 29.13, V = 3.47 m/s) and one patient has cirrhosis with ascites, (BMI = 21.11, V = 1.83 m/s).
Transient elastography was performed using a FibroScan® device (Echosens,Paris,France). Patients were in supine position, with the right arm in maximum abduction. The Fibroscan transducer was placed perpendicularly in the intercostal space. The sonologist would choose a liver portion in the right lobe, free from any large vascular structures or the gallbladder. Transient elastography measures the stiffness in an area located 40 mm from the liver capsule. The mean value of 6 to 10 successful acquisitions is recorded in kilopascals (kPa). We considered as representative 6 to10 successful acquisitions with a success rate of at least 60%.
ARFI was performed in all patients by an ultrasound system ACUSON S2000 (Siemens). The convex transducer (4C1) is placed gently on the patient's skin in the right upper quadrant, along the same intercostal space which was used for the TE measurement. The region of interest for measuring the ARFI was chosen 4 cm below the skin level, free from any large vascular structures or the gallbladder. When scanning between ribs, the patient was asked to hold breathing for a moment. The mean velocity of 3 successful VTQ measurements was used for the statistical analysis (Figure 1) . ARFI values are compared to TE values by MedCalc statistical analysis software, and serologic markers tests (in the same day) are the standard references. We did not use the histological results from biopsy for comparison in the present study.
Images for this section: There are significant statistical differences between V0-V1, V1-V2, V2-V3, V3-V4 with t range from 11.74 to 20.66 (p < 0.0001) and statistical differences between V0,1,2-V3,4 t = 27.32 (p < 0.0001) (Figure 7 ).
There are close clinical agreements between FibroScan F4 and ARFI V4, kappa=0.767 (Figure 8 ).
We measured the values of ARFI in 1 times, 3 times, 5 times and 10 times in 32 cases, then collected the average value and standard deviation of each measurement and statistics. Results: -There are not significant statistical differences between groups with t range from 0.00637 to 0.0823 (p = 0,9346 à 0,9949) and there are not statistical differences between standard deviation of groups with t = 0.104 à 0.472 (p = 0.6387 à 0.9174). 
Discussion
In recent years, non-invasive methods for liver fibrosis assessment in chronic hepatitis virus have been developed, such as FibroTest, Transient Elastography (Fibroscan), Supersonic Shear Imaging, Acoustic Radiation Force Impulse Imaging (Siemens Acuson S2000 Virtual Touch). Fibrotest and TE Fibroscan has been commonly used in clinical practice. However, they are still not the gold standard in diagnosing chronic liver diseases.
ARFI is a new technique of noninvasive elastography for evaluation of liver fibrosis and the stiffness of other pathologic organs (thyroid, breast, prostate, spleen, kidney and muscular skeletal system, etc). In our study, ARFI measurements have a close correlation with TE (r= 0.8005, p<0.0001). In addition, there is a good clinical agreement between ARFI V4 and TE F4 (kappa = 0.767). Thus the accuracy of diagnosing of cirrhosis of ARFI and TE is similar.
In comparison to other study, the value of correlative coefficient r in the present study (r = 0.805, 586 cases) is higher than study of Sporea et al, 2010, (r = 0.532, 71 cases). This may be due to our larger sample and the attainment of ARFI and TE measurements in the same location.
From the regression equation, we propose a reference for staging of liver fibrosis ( Comparison the mean value velocity by ARFI in the present study to other studies ( Figure  9 ).
From the determined the mean value of each stage, and the t test value showed significant statistical differences between stages (t = 11.74 à 20.66, p < 0.0001).
The integration of ARFI technique in conventional ultrasound system (B mode and Doppler) is a workflow advantage for assessment of liver fibrosis and other diseases during an ultrasound examination. This is not feasible with Fibroscan.
In this study TE did not measure for 2 cases (1 case of cirrhosis and large ascites with BMI = 21.11 and an obesity case with BMI = 29.13), but all could be measured with ARFI.
ARFI measurements were performed several times to avoid measurement error. However, results derived from 5 measurements were more suitable than 10 measurements. In our experience with ARFI, patients need to hold their breath. When they hold breath too many times can be make change the intra-abdominal pressure, along with the fixed ROI is no longer accurate.
The limits of this research is lack of microscopic liver biopsy data.
We think ARFI technique is a potential assessment for liver fibrosis evaluation and strain imaging in clinical practice. 
